Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia

Completed · Not applicable

Conditions studied: Fibromyalgia, Fibromyalgia Syndrome

In brief

In this pilot study we propose to gather preliminary data on whether transdermal magnesium chloride can improve quality of life in patients with fibromyalgia. Forty women with fibromyalgia will be enrolled in this study. Participants will be asked to apply a topical solution of magnesium chloride on their extremities 3 times daily for 28 consecutive days. Three questionnaires measuring quality of life will be administered at baseline, at 2 weeks, and at 4 weeks (end of study).

Key facts

Study ID

NCT01968772

Run by

Mayo Clinic

People needed

40

Starts

2013-10-01

Expected to finish

2014-09-01

Last updated by the study team

2014-12-24

Who can join

Age: 40 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with fibromyalgia at Mayo Clinic Rochester's Fibromyalgia Clinic
• Postmenopausal women (no menstrual period for 1 year or more)
• Women age 40-70 that have had a hysterectomy
• Willing to travel to Mayo Clinic Rochester for the initial instruction visit
• Able to apply the transdermal magnesium chloride as directed
• Able to complete the questionnaires and daily diary
• Able and willing to give informed consent
• Able to speak, write and understand English

You may not qualify if…

• Patients on dialysis
• Individuals who decline to participate in the study
• Diagnoses of bipolar disorder, schizophrenia or dementia
• Patients with myasthenia gravis and myasthenic syndromes
• Patients on magnesium supplements

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.